{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:51:59Z","timestamp":1775933519914,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejps.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T17:51:04Z","timestamp":1539280264000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery"],"prefix":"10.1016","volume":"125","author":[{"given":"Silvia","family":"Pescina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Garrastazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"del Favero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cant\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-524X","authenticated-orcid":false,"given":"Cristina","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-7894","authenticated-orcid":false,"given":"Patrizia","family":"Santi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-0957","authenticated-orcid":false,"given":"Sara","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.10.007_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/10915818309142002","article-title":"4 final report on the safety assessment of Isostearic acid","volume":"2","author":"4 Final Report on the Safety Assessment of Isostearic Acid","year":"1983","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1023\/A:1015921702258","article-title":"Structure\/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants","volume":"6","author":"Aungst","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.007_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/abio.2000.4977","article-title":"Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum","volume":"290","author":"Beisson","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2018.10.007_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2018.04.049","article-title":"Development of microemulsions of suitable viscosity for cyclosporine skin delivery","volume":"545","author":"Benigni","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0025","article-title":"The A2V mutation as a new tool for hindering A\u03b2 aggregation: a neutron and x-ray diffraction study","volume":"7","author":"Cant\u00f9","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2018.10.007_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10837459908984222","article-title":"Development of a topically active imiquimod formulation","volume":"4","author":"Chollet","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/mp060121r","article-title":"Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity","volume":"4","author":"Collnot","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2010.03.005","article-title":"Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release","volume":"40","author":"Goddeeris","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.007_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/acs.molpharmaceut.7b00939","article-title":"Poloxamer 407\/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery","volume":"15","author":"Grimaudo","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","article-title":"The applications of vitamin E TPGS in drug delivery","volume":"49","author":"Guo","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.007_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2004.10.030","article-title":"Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs","volume":"102","author":"Ke","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.007_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2012.04.079","article-title":"Distribution of esterase activity in porcine ear skin, and the effects of freezing and heat separation","volume":"433","author":"Lau","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.colsurfb.2015.12.047","article-title":"Omega-3 fatty acids incorporated colloidal systems for the delivery of Angelica gigas Nakai extract","volume":"140","author":"Lee","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"Suppl. 3","key":"10.1016\/j.ejps.2018.10.007_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1468-3083.2005.01330.x","article-title":"Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis","volume":"19","author":"Marty","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17425247.2016.1229300","article-title":"Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery","volume":"14","author":"Muddineti","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.007_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000135638","article-title":"Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability","volume":"21","author":"Nicoli","year":"2008","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40005-016-0300-x","article-title":"Application of d-\u03b1-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)","volume":"47","author":"Pham","year":"2017","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2018.10.007_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2016.10.010","article-title":"Chitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesion","volume":"110","author":"Sandri","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"Suppl. 2","key":"10.1016\/j.ejps.2018.10.007_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","article-title":"Imiquimod: mode of action","volume":"157","author":"Schon","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1211\/jpp.59.6.0005","article-title":"Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE)","volume":"59","author":"Suppasansatorn","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.007_bb0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2016.07.043","article-title":"Mechanisms of imiquimod skin penetration","volume":"511","author":"Telo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0110","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.7b00348","article-title":"Gel-like TPGS-based microemulsions for imiquimod dermal delivery: role of mesostructure on the uptake and distribution into the skin","volume":"14","author":"Tel\u00f2","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2018.10.007_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijpharm.2017.06.050","article-title":"Dual roles of TPGS based microemulsion for tacrolimus: enhancing the percutaneous delivery and anti-psoriatic efficacy","volume":"528","author":"Wan","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.007_bb0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7150\/thno.22711","article-title":"Recent advances in the application of vitamin E TPGS for drug delivery","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2018.10.007_bb0130","first-page":"642","article-title":"Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics","volume":"64","author":"Yao","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2018.10.007_bb0135","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.biomaterials.2012.03.046","article-title":"Vitamin E TPGS as a molecular biomaterial for drug delivery","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:29:26Z","timestamp":1749238166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718304548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"alternative-id":["S0928098718304548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.007","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}